news
Dr Richard Torbett named as new ABPI Chief Executive
The ABPI’s board has unanimously appointed Dr Richard Torbett as…
The ABPI’s board has unanimously appointed Dr Richard Torbett as Chief Executive, commencing 1 January 2020.
List view / Grid view
Mike Thompson
news
ABPI release medicine manifesto for new UK government after election
The ABPI’s Manifesto for Medicine has been issued, calling upon…
The ABPI’s Manifesto for Medicine has been issued, calling upon the next government in the UK to work closely with the pharma industry to increase innovation and access to medicines.
news
Leaked government document reveals possibility of no-deal Brexit drug shortages
A leaked government dossier has stated that in the event…
A leaked government dossier has stated that in the event of a no-deal Brexit, the UK will face severe medicinal shortages.
news
ABPI finds £377 million spent on UK R&D
The ABPI has reported findings from its transparency initiative, Disclosure…
The ABPI has reported findings from its transparency initiative, Disclosure UK, stating that R&D investment grew significantly from 2017 to 2018.
news
Government letter advises pharma industry for no-deal Brexit
The government has issued a letter to the pharmaceutical industry,…
The government has issued a letter to the pharmaceutical industry, outlining how to prepare for a no-deal Brexit.
news
New initiative launched to boost Northern Ireland’s life science industry
The UK’s newest life sciences asset, Health Innovation Research Alliance…
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
news
Pharma industry ‘call for action’ following Brexit vote
The pharma industry has called for the government to act…
The pharma industry has called for the government to act to ensure that patients receive their medications in the case of a ‘no deal’ situation...
news
Joint policy document shows the potential impact of Brexit
The associations representing the European and British life science industry…
The associations representing the European and British life science industry have launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union...
news
Budget 2017: Reaction from the UK’s pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical…
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
news
Bluebird bio joins the ABPI as a full member
The Association of the British Pharmaceutical Industry (ABPI) has admitted…
The Association of the British Pharmaceutical Industry (ABPI) has admitted the American biotech bluebird bio, Inc. as a full member...
news
ABPI respond to statement of UK Government’s medicines regulation plans
The ABPI has responded to a joint letter from Jeremy…
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
